These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33704735)

  • 1. Assessment of Cell-Free microRNA by NGS Whole-Transcriptome Analysis in Cutaneous Melanoma Patients' Blood.
    Tran KD; Gross R; Rahimzadeh N; Chenathukattil S; Hoon DSB; Bustos MA
    Methods Mol Biol; 2021; 2265():475-486. PubMed ID: 33704735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pilot Study Comparing the Efficacy of Lactate Dehydrogenase Levels Versus Circulating Cell-Free microRNAs in Monitoring Responses to Checkpoint Inhibitor Immunotherapy in Metastatic Melanoma Patients.
    Bustos MA; Gross R; Rahimzadeh N; Cole H; Tran LT; Tran KD; Takeshima L; Stern SL; O'Day S; Hoon DSB
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33202891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Assessment of Circulating Cell-Free MicroRNA Signatures in Plasma of Patients with Melanoma Brain Metastasis.
    Bustos MA; Tran KD; Rahimzadeh N; Gross R; Lin SY; Shoji Y; Murakami T; Boley CL; Tran LT; Cole H; Kelly DF; O'Day S; Hoon DSB
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32630542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
    Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
    Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miRNA expression analysis reveals new potential biomarkers for human cutaneous melanoma staging.
    Sánchez-Sendra B; García-Giménez JL; González-Muñoz JF; Navarro L; Murgui A; Terrádez L; Pinazo I; Martin JM; Monteagudo C
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):e126-e129. PubMed ID: 31710393
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell-free plasma microRNAs that identify patients with glioblastoma.
    Bustos MA; Rahimzadeh N; Ryu S; Gross R; Tran LT; Renteria-Lopez VM; Ramos RI; Eisenberg A; Hothi P; Kesari S; Barkhoudarian G; Takasumi Y; Cobbs C; Kelly DF; Hoon DSB
    Lab Invest; 2022 Jul; 102(7):711-721. PubMed ID: 35013528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma.
    Armand-Labit V; Meyer N; Casanova A; Bonnabau H; Platzer V; Tournier E; Sansas B; Verdun S; Thouvenot B; Hilselberger B; Doncescu A; Lamant L; Lacroix-Triki M; Favre G; Pradines A
    Acta Derm Venereol; 2016 Jan; 96(1):29-34. PubMed ID: 26039581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma.
    Carpi S; Polini B; Fogli S; Podestà A; Ylösmäki E; Cerullo V; Romanini A; Nieri P
    Expert Rev Mol Diagn; 2020 Jan; 20(1):19-30. PubMed ID: 31747311
    [No Abstract]   [Full Text] [Related]  

  • 9. Tissue microRNA expression profiling in hepatic and pulmonary metastatic melanoma.
    DiVincenzo MJ; Latchana N; Abrams Z; Moufawad M; Regan-Fendt K; Courtney NB; Howard JH; Gru AA; Zhang X; Fadda P; Carson WE
    Melanoma Res; 2020 Oct; 30(5):455-464. PubMed ID: 32804708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients.
    Ono S; Oyama T; Lam S; Chong K; Foshag LJ; Hoon DS
    Oncotarget; 2015 Mar; 6(9):7053-64. PubMed ID: 25749524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs that predict the effectiveness of anti-PD-1 therapies in patients with advanced melanoma.
    Nakahara S; Fukushima S; Okada E; Morinaga J; Kubo Y; Tokuzumi A; Matsumoto S; Tsuruta-Kadohisa M; Kimura T; Kuriyama H; Miyashita A; Kajihara I; Jinnin M; Ihn H
    J Dermatol Sci; 2020 Jan; 97(1):77-79. PubMed ID: 31843231
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitive detection of melanoma metastasis using circulating microRNA expression profiles.
    Shiiyama R; Fukushima S; Jinnin M; Yamashita J; Miyashita A; Nakahara S; Kogi A; Aoi J; Masuguchi S; Inoue Y; Ihn H
    Melanoma Res; 2013 Oct; 23(5):366-72. PubMed ID: 23863473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating cell-free microRNAs in cutaneous melanoma staging and recurrence or survival prognosis.
    Polini B; Carpi S; Romanini A; Breschi MC; Nieri P; Podestà A
    Pigment Cell Melanoma Res; 2019 Jul; 32(4):486-499. PubMed ID: 30481404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma.
    Fogli S; Polini B; Carpi S; Pardini B; Naccarati A; Dubbini N; Lanza M; Breschi MC; Romanini A; Nieri P
    Tumour Biol; 2017 May; 39(5):1010428317701646. PubMed ID: 28466785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression.
    Grimolizzi F; Monaco F; Leoni F; Bracci M; Staffolani S; Bersaglieri C; Gaetani S; Valentino M; Amati M; Rubini C; Saccucci F; Neuzil J; Tomasetti M; Santarelli L
    Sci Rep; 2017 Nov; 7(1):15277. PubMed ID: 29127370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine Cell-Free MicroRNAs in Localized Prostate Cancer Patients.
    Koh Y; Bustos MA; Moon J; Gross R; Ramos RI; Ryu S; Choe J; Lin SY; Allen WM; Krasne DL; Wilson TG; Hoon DSB
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35625992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel microRNA profile in pediatric patients with cancer treated with anthracycline chemotherapy.
    Oatmen KE; Toro-Salazar OH; Hauser K; Zellars KN; Mason KC; Hor K; Gillan E; Zeiss CJ; Gatti DM; Spinale FG
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1443-H1452. PubMed ID: 30141982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic identification of miR-205 target genes potentially involved in metastasis and survival of cutaneous malignant melanoma.
    Sánchez-Sendra B; Serna E; Navarro L; González-Muñoz JF; Portero J; Ramos A; Murgui A; Monteagudo C
    Sci Rep; 2020 Mar; 10(1):4771. PubMed ID: 32179834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of circulating microRNA-125b levels in serum exosomes in advanced melanoma.
    Alegre E; Sanmamed MF; Rodriguez C; Carranza O; Martín-Algarra S; González A
    Arch Pathol Lab Med; 2014 Jun; 138(6):828-32. PubMed ID: 24878024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative Analysis of Long Noncoding RNA (lncRNA), microRNA (miRNA) and mRNA Expression and Construction of a Competing Endogenous RNA (ceRNA) Network in Metastatic Melanoma.
    Wang LX; Wan C; Dong ZB; Wang BH; Liu HY; Li Y
    Med Sci Monit; 2019 Apr; 25():2896-2907. PubMed ID: 31004080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.